series-b
Stage
2017
Founded
10
Investors
About
Tubulis is developing a pipeline of uniquely matched antibody-drug conjugates (ADCs) to treat a variety of solid tumors, leveraging proprietary platforms to create safer and more effective cancer therapies.
Explore Tubulis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.